While LVEF, LVEDD, 6 MWT, heart rate and BNP are established prognostic markers in HF, our study specifically demonstrates their predictive value for treatment response to Ivab-Met-S combination therapy. This evidence concerns the gene NPPB and hydrops fetalis.